News stories about U.S. Physical Therapy (NYSE:USPH) have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. U.S. Physical Therapy earned a daily sentiment score of 0.04 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.4340872523484 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

A number of equities research analysts recently issued reports on the stock. Cantor Fitzgerald reiterated a “buy” rating and set a $80.00 target price on shares of U.S. Physical Therapy in a research report on Tuesday, January 9th. BidaskClub upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, October 25th. Zacks Investment Research cut shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Saturday, October 7th. Finally, Barrington Research cut shares of U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research report on Friday, November 3rd. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. U.S. Physical Therapy currently has a consensus rating of “Buy” and an average price target of $73.80.

Shares of U.S. Physical Therapy (NYSE:USPH) opened at $74.95 on Wednesday. The stock has a market cap of $942.96, a PE ratio of 45.15, a P/E/G ratio of 2.77 and a beta of 1.09. The company has a current ratio of 2.04, a quick ratio of 2.04 and a debt-to-equity ratio of 0.30. U.S. Physical Therapy has a 1 year low of $56.50 and a 1 year high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, November 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.04). The firm had revenue of $103.03 million for the quarter, compared to analyst estimates of $102.69 million. U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%. analysts expect that U.S. Physical Therapy will post 2.07 earnings per share for the current fiscal year.

In other U.S. Physical Therapy news, CFO Lawrance W. Mcafee sold 800 shares of the stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $69.21, for a total transaction of $55,368.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Mark J. Brookner sold 2,625 shares of the stock in a transaction dated Wednesday, December 27th. The stock was sold at an average price of $71.23, for a total transaction of $186,978.75. The disclosure for this sale can be found here. Insiders have sold a total of 31,875 shares of company stock valued at $2,173,623 in the last quarter. 3.10% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: “U.S. Physical Therapy (USPH) Earning Somewhat Positive News Coverage, Study Finds” was published by Watch List News and is the property of of Watch List News. If you are reading this news story on another publication, it was illegally copied and republished in violation of United States & international copyright law. The legal version of this news story can be viewed at

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with's FREE daily email newsletter.